Industry Research Reports

Home > Reports > Service & Software > Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Service & Software

Published Date: 2024-02-22

Pages: 110 Pages

Report ld: 2554241

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Tissue-Based Diagnostics Market Size(US$)

CAGR 2024-2030

6.7%

Market Size,2030

USD 8,054.2

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 5,458 million

Market Forecast in 2030(Value)

US$ 8,054.2 million

CAGR

6.7%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5321 million in 2023 and is forecast to a readjusted size of US$ 8054.2 million by 2030 with a CAGR of 6.7% during the forecast period 2024-2030

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

MARKET SEGMENTATION

By Company

Roche
Danaher
Thermo Fisher Scientific
Abbott
Agilent Technologies
ABCAM
Merck
BD
Hologic
Bio Rad

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Digital Pathology and Workflow Management
Special Staining

Segment by Application

Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Other

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Tissue-Based Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Tissue-Based Diagnostics by region & country, by Type, and by Application.

The Tissue-Based Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tissue-Based Diagnostics.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Tissue-Based Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Tissue-Based Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Tissue-Based Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Tissue-Based Diagnostics Product Introduction

1.2 Global Tissue-Based Diagnostics Market Size Forecast

1.3 Tissue-Based Diagnostics Market Trends & Drivers

1.3.1 Tissue-Based Diagnostics Industry Trends

1.3.2 Tissue-Based Diagnostics Market Drivers & Opportunity

1.3.3 Tissue-Based Diagnostics Market Challenges

1.3.4 Tissue-Based Diagnostics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Tissue-Based Diagnostics Players Revenue Ranking (2023)

2.2 Global Tissue-Based Diagnostics Revenue by Company (2019-2024)

2.3 Key Companies Tissue-Based Diagnostics Manufacturing Base Distribution and Headquarters

2.4 Key Companies Tissue-Based Diagnostics Product Offered

2.5 Key Companies Time to Begin Mass Production of Tissue-Based Diagnostics

2.6 Tissue-Based Diagnostics Market Competitive Analysis

2.6.1 Tissue-Based Diagnostics Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Tissue-Based Diagnostics Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tissue-Based Diagnostics as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Immunohistochemistry (IHC)

3.1.2 In Situ Hybridization (ISH)

3.1.3 Digital Pathology and Workflow Management

3.1.4 Special Staining

3.2 Global Tissue-Based Diagnostics Sales Value by Type

3.2.1 Global Tissue-Based Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Tissue-Based Diagnostics Sales Value, by Type (2019-2030)

3.2.3 Global Tissue-Based Diagnostics Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Research Laboratories

4.1.3 Pharmaceutical Companies

4.1.4 Contract Research Organizations

4.1.5 Other

4.2 Global Tissue-Based Diagnostics Sales Value by Application

4.2.1 Global Tissue-Based Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Tissue-Based Diagnostics Sales Value, by Application (2019-2030)

4.2.3 Global Tissue-Based Diagnostics Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Tissue-Based Diagnostics Sales Value by Region

5.1.1 Global Tissue-Based Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Tissue-Based Diagnostics Sales Value by Region (2019-2024)

5.1.3 Global Tissue-Based Diagnostics Sales Value by Region (2025-2030)

5.1.4 Global Tissue-Based Diagnostics Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Tissue-Based Diagnostics Sales Value, 2019-2030

5.2.2 North America Tissue-Based Diagnostics Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Tissue-Based Diagnostics Sales Value, 2019-2030

5.3.2 Europe Tissue-Based Diagnostics Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Tissue-Based Diagnostics Sales Value, 2019-2030

5.4.2 Asia Pacific Tissue-Based Diagnostics Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Tissue-Based Diagnostics Sales Value, 2019-2030

5.5.2 South America Tissue-Based Diagnostics Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Tissue-Based Diagnostics Sales Value, 2019-2030

5.6.2 Middle East & Africa Tissue-Based Diagnostics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Tissue-Based Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Tissue-Based Diagnostics Sales Value

6.3 United States

6.3.1 United States Tissue-Based Diagnostics Sales Value, 2019-2030

6.3.2 United States Tissue-Based Diagnostics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Tissue-Based Diagnostics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Tissue-Based Diagnostics Sales Value, 2019-2030

6.4.2 Europe Tissue-Based Diagnostics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Tissue-Based Diagnostics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Tissue-Based Diagnostics Sales Value, 2019-2030

6.5.2 China Tissue-Based Diagnostics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Tissue-Based Diagnostics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Tissue-Based Diagnostics Sales Value, 2019-2030

6.6.2 Japan Tissue-Based Diagnostics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Tissue-Based Diagnostics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Tissue-Based Diagnostics Sales Value, 2019-2030

6.7.2 South Korea Tissue-Based Diagnostics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Tissue-Based Diagnostics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Tissue-Based Diagnostics Sales Value, 2019-2030

6.8.2 Southeast Asia Tissue-Based Diagnostics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Tissue-Based Diagnostics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Tissue-Based Diagnostics Sales Value, 2019-2030

6.9.2 India Tissue-Based Diagnostics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Tissue-Based Diagnostics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Roche

7.1.1 Roche Profile

7.1.2 Roche Main Business

7.1.3 Roche Tissue-Based Diagnostics Products, Services and Solutions

7.1.4 Roche Tissue-Based Diagnostics Revenue (US$ Million) & (2019-2024)

7.1.5 Roche Recent Developments

7.2 Danaher

7.2.1 Danaher Profile

7.2.2 Danaher Main Business

7.2.3 Danaher Tissue-Based Diagnostics Products, Services and Solutions

7.2.4 Danaher Tissue-Based Diagnostics Revenue (US$ Million) & (2019-2024)

7.2.5 Danaher Recent Developments

7.3 Thermo Fisher Scientific

7.3.1 Thermo Fisher Scientific Profile

7.3.2 Thermo Fisher Scientific Main Business

7.3.3 Thermo Fisher Scientific Tissue-Based Diagnostics Products, Services and Solutions

7.3.4 Thermo Fisher Scientific Tissue-Based Diagnostics Revenue (US$ Million) & (2019-2024)

7.3.5 Abbott Recent Developments

7.4 Abbott

7.4.1 Abbott Profile

7.4.2 Abbott Main Business

7.4.3 Abbott Tissue-Based Diagnostics Products, Services and Solutions

7.4.4 Abbott Tissue-Based Diagnostics Revenue (US$ Million) & (2019-2024)

7.4.5 Abbott Recent Developments

7.5 Agilent Technologies

7.5.1 Agilent Technologies Profile

7.5.2 Agilent Technologies Main Business

7.5.3 Agilent Technologies Tissue-Based Diagnostics Products, Services and Solutions

7.5.4 Agilent Technologies Tissue-Based Diagnostics Revenue (US$ Million) & (2019-2024)

7.5.5 Agilent Technologies Recent Developments

7.6 ABCAM

7.6.1 ABCAM Profile

7.6.2 ABCAM Main Business

7.6.3 ABCAM Tissue-Based Diagnostics Products, Services and Solutions

7.6.4 ABCAM Tissue-Based Diagnostics Revenue (US$ Million) & (2019-2024)

7.6.5 ABCAM Recent Developments

7.7 Merck

7.7.1 Merck Profile

7.7.2 Merck Main Business

7.7.3 Merck Tissue-Based Diagnostics Products, Services and Solutions

7.7.4 Merck Tissue-Based Diagnostics Revenue (US$ Million) & (2019-2024)

7.7.5 Merck Recent Developments

7.8 BD

7.8.1 BD Profile

7.8.2 BD Main Business

7.8.3 BD Tissue-Based Diagnostics Products, Services and Solutions

7.8.4 BD Tissue-Based Diagnostics Revenue (US$ Million) & (2019-2024)

7.8.5 BD Recent Developments

7.9 Hologic

7.9.1 Hologic Profile

7.9.2 Hologic Main Business

7.9.3 Hologic Tissue-Based Diagnostics Products, Services and Solutions

7.9.4 Hologic Tissue-Based Diagnostics Revenue (US$ Million) & (2019-2024)

7.9.5 Hologic Recent Developments

7.10 Bio Rad

7.10.1 Bio Rad Profile

7.10.2 Bio Rad Main Business

7.10.3 Bio Rad Tissue-Based Diagnostics Products, Services and Solutions

7.10.4 Bio Rad Tissue-Based Diagnostics Revenue (US$ Million) & (2019-2024)

7.10.5 Bio Rad Recent Developments

8 Industry Chain Analysis

8.1 Tissue-Based Diagnostics Industrial Chain

8.2 Tissue-Based Diagnostics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Tissue-Based Diagnostics Sales Model

8.5.2 Sales Channel

8.5.3 Tissue-Based Diagnostics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Tissue-Based Diagnostics Market Trends

Table 2. Tissue-Based Diagnostics Market Drivers & Opportunity

Table 3. Tissue-Based Diagnostics Market Challenges

Table 4. Tissue-Based Diagnostics Market Restraints

Table 5. Global Tissue-Based Diagnostics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Tissue-Based Diagnostics Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Tissue-Based Diagnostics Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Tissue-Based Diagnostics Product Type

Table 9. Key Companies Time to Begin Mass Production of Tissue-Based Diagnostics

Table 10. Global Tissue-Based Diagnostics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tissue-Based Diagnostics as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Tissue-Based Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Tissue-Based Diagnostics Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Tissue-Based Diagnostics Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Tissue-Based Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Tissue-Based Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Tissue-Based Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Tissue-Based Diagnostics Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Tissue-Based Diagnostics Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Tissue-Based Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Tissue-Based Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Tissue-Based Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Tissue-Based Diagnostics Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Tissue-Based Diagnostics Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Tissue-Based Diagnostics Sales Value by Region (2019-2024) & (%)

Table 27. Global Tissue-Based Diagnostics Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Tissue-Based Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Tissue-Based Diagnostics Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Tissue-Based Diagnostics Sales Value, (2025-2030) & (US$ Million)

Table 31. Roche Basic Information List

Table 32. Roche Description and Business Overview

Table 33. Roche Tissue-Based Diagnostics Products, Services and Solutions

Table 34. Revenue (US$ Million) in Tissue-Based Diagnostics Business of Roche (2019-2024)

Table 35. Roche Recent Developments

Table 36. Danaher Basic Information List

Table 37. Danaher Description and Business Overview

Table 38. Danaher Tissue-Based Diagnostics Products, Services and Solutions

Table 39. Revenue (US$ Million) in Tissue-Based Diagnostics Business of Danaher (2019-2024)

Table 40. Danaher Recent Developments

Table 41. Thermo Fisher Scientific Basic Information List

Table 42. Thermo Fisher Scientific Description and Business Overview

Table 43. Thermo Fisher Scientific Tissue-Based Diagnostics Products, Services and Solutions

Table 44. Revenue (US$ Million) in Tissue-Based Diagnostics Business of Thermo Fisher Scientific (2019-2024)

Table 45. Thermo Fisher Scientific Recent Developments

Table 46. Abbott Basic Information List

Table 47. Abbott Description and Business Overview

Table 48. Abbott Tissue-Based Diagnostics Products, Services and Solutions

Table 49. Revenue (US$ Million) in Tissue-Based Diagnostics Business of Abbott (2019-2024)

Table 50. Abbott Recent Developments

Table 51. Agilent Technologies Basic Information List

Table 52. Agilent Technologies Description and Business Overview

Table 53. Agilent Technologies Tissue-Based Diagnostics Products, Services and Solutions

Table 54. Revenue (US$ Million) in Tissue-Based Diagnostics Business of Agilent Technologies (2019-2024)

Table 55. Agilent Technologies Recent Developments

Table 56. ABCAM Basic Information List

Table 57. ABCAM Description and Business Overview

Table 58. ABCAM Tissue-Based Diagnostics Products, Services and Solutions

Table 59. Revenue (US$ Million) in Tissue-Based Diagnostics Business of ABCAM (2019-2024)

Table 60. ABCAM Recent Developments

Table 61. Merck Basic Information List

Table 62. Merck Description and Business Overview

Table 63. Merck Tissue-Based Diagnostics Products, Services and Solutions

Table 64. Revenue (US$ Million) in Tissue-Based Diagnostics Business of Merck (2019-2024)

Table 65. Merck Recent Developments

Table 66. BD Basic Information List

Table 67. BD Description and Business Overview

Table 68. BD Tissue-Based Diagnostics Products, Services and Solutions

Table 69. Revenue (US$ Million) in Tissue-Based Diagnostics Business of BD (2019-2024)

Table 70. BD Recent Developments

Table 71. Hologic Basic Information List

Table 72. Hologic Description and Business Overview

Table 73. Hologic Tissue-Based Diagnostics Products, Services and Solutions

Table 74. Revenue (US$ Million) in Tissue-Based Diagnostics Business of Hologic (2019-2024)

Table 75. Hologic Recent Developments

Table 76. Bio Rad Basic Information List

Table 77. Bio Rad Description and Business Overview

Table 78. Bio Rad Tissue-Based Diagnostics Products, Services and Solutions

Table 79. Revenue (US$ Million) in Tissue-Based Diagnostics Business of Bio Rad (2019-2024)

Table 80. Bio Rad Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Tissue-Based Diagnostics Downstream Customers

Table 84. Tissue-Based Diagnostics Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Tissue-Based Diagnostics Product Picture

Figure 2. Global Tissue-Based Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Tissue-Based Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 4. Tissue-Based Diagnostics Report Years Considered

Figure 5. Global Tissue-Based Diagnostics Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Tissue-Based Diagnostics Revenue in 2023

Figure 7. Tissue-Based Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Immunohistochemistry (IHC) Picture

Figure 9. In Situ Hybridization (ISH) Picture

Figure 10. Digital Pathology and Workflow Management Picture

Figure 11. Special Staining Picture

Figure 12. Global Tissue-Based Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global Tissue-Based Diagnostics Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Hospitals

Figure 15. Product Picture of Research Laboratories

Figure 16. Product Picture of Pharmaceutical Companies

Figure 17. Product Picture of Contract Research Organizations

Figure 18. Product Picture of Other

Figure 19. Global Tissue-Based Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 20. Global Tissue-Based Diagnostics Sales Value Market Share by Application, 2023 & 2030

Figure 21. North America Tissue-Based Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 22. North America Tissue-Based Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 23. Europe Tissue-Based Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 24. Europe Tissue-Based Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 25. Asia Pacific Tissue-Based Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 26. Asia Pacific Tissue-Based Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 27. South America Tissue-Based Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 28. South America Tissue-Based Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 29. Middle East & Africa Tissue-Based Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 30. Middle East & Africa Tissue-Based Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 31. Key Countries/Regions Tissue-Based Diagnostics Sales Value (%), (2019-2030)

Figure 32. United States Tissue-Based Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 33. United States Tissue-Based Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 34. United States Tissue-Based Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 35. Europe Tissue-Based Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 36. Europe Tissue-Based Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 37. Europe Tissue-Based Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 38. China Tissue-Based Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 39. China Tissue-Based Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 40. China Tissue-Based Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 41. Japan Tissue-Based Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 42. Japan Tissue-Based Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 43. Japan Tissue-Based Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 44. South Korea Tissue-Based Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 45. South Korea Tissue-Based Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 46. South Korea Tissue-Based Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 47. Southeast Asia Tissue-Based Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Tissue-Based Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 49. Southeast Asia Tissue-Based Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 50. India Tissue-Based Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 51. India Tissue-Based Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 52. India Tissue-Based Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 53. Tissue-Based Diagnostics Industrial Chain

Figure 54. Tissue-Based Diagnostics Manufacturing Cost Structure

Figure 55. Channels of Distribution (Direct Sales, and Distribution)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 6.7% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What was the global market size of Tissue-Based Diagnostics in 2030? shouQi

What is the annual compound growth rate of the global Tissue-Based Diagnostics market size from 2024 to 2030? shouQi

What was the global market size of Tissue-Based Diagnostics in 2024? shouQi

Which companies rank high in the global Tissue-Based Diagnostics market? shouQi

Related Reports

Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 6136 million in 2025 and is projected to reach US$ 9601 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-07-09
Pages: 105
USD 3950.00
(Single User License)
Global Tissue-Based Diagnostics Market Research Report 2026
The global Tissue-Based Diagnostics market was valued at US$ 6136 million in 2025 and is anticipated to reach US$ 9601 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-04-21
Pages: 110
USD 2900.00
(Single User License)
Global Tissue-Based Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tissue-Based Diagnostics market is projected to grow from US$ 5787 million in 2024 to US$ 9055 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-25
Pages: 129
USD 4900.00
(Single User License)
Global Tissue-Based Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tissue-Based Diagnostics market size was US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 78
USD 4250.00
(Single User License)
Tissue-Based Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 99
USD 3950.00
(Single User License)
Global Tissue-Based Diagnostics Market Research Report 2025
The global market for Tissue-Based Diagnostics was valued at US$ 5787 million in the year 2024 and is projected to reach a revised size of US$ 9055 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published Date: 2025-02-21
Pages: 72
USD 2900.00
(Single User License)
Global Tissue-Based Diagnostics Market Insights, Forecast to 2030
Market Analysis and Insights: Global Tissue-Based Diagnostics Market
Published Date: 2024-04-08
Pages: 110
USD 4900.00
(Single User License)
Global Tissue-Based Diagnostics Market Research Report 2024
The global Tissue-Based Diagnostics market was valued at US$ 5321 million in 2023 and is anticipated to reach US$ 8054.2 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
Published Date: 2024-02-06
Pages: 81
USD 2900.00
(Single User License)

Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 6136 million in 2025 and is projected to reach US$ 9601 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-07-09
Pages: 105
USD 3950.00 (Single User License)
Global Tissue-Based Diagnostics Market Research Report 2026
The global Tissue-Based Diagnostics market was valued at US$ 6136 million in 2025 and is anticipated to reach US$ 9601 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-04-21
Pages: 110
USD 2900.00 (Single User License)
Global Tissue-Based Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tissue-Based Diagnostics market is projected to grow from US$ 5787 million in 2024 to US$ 9055 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-25
Pages: 129
USD 4900.00 (Single User License)
Global Tissue-Based Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tissue-Based Diagnostics market size was US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 78
USD 4250.00 (Single User License)
Tissue-Based Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 99
USD 3950.00 (Single User License)
Global Tissue-Based Diagnostics Market Research Report 2025
The global market for Tissue-Based Diagnostics was valued at US$ 5787 million in the year 2024 and is projected to reach a revised size of US$ 9055 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-02-21
Pages: 72
USD 2900.00 (Single User License)
Global Tissue-Based Diagnostics Market Insights, Forecast to 2030
Market Analysis and Insights: Global Tissue-Based Diagnostics Market
Published: 2024-04-08
Pages: 110
USD 4900.00 (Single User License)
Global Tissue-Based Diagnostics Market Research Report 2024
The global Tissue-Based Diagnostics market was valued at US$ 5321 million in 2023 and is anticipated to reach US$ 8054.2 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
Published: 2024-02-06
Pages: 81
USD 2900.00 (Single User License)